Abstract
The accurate prediction of the in vivo pharmacokinetics of a new potential drug compound based on only its virtual structure is the ultimate goal of in silico ADME-Tox property modeling. A comprehensive review is made on recent studies concerning the A (absorption) in ADME-Tox, i.e. the in silico modeling of both Caco-2 permeability and human intestinal absorption. The data sets used, the descriptors selected to build the models, the variable selection methods, the modeling techniques and the performed model validation are critically discussed. It was concluded that reliable models which improve the success rate of compound selection and drug development are still lacking. Limiting the quality of the models are, for instance, inappropriate compilation of data sets, lack of an appropriate outlier detection and unrepresentativeness of training and test sets for the data population. The definition of some best practices or guidelines for the different steps of the modeling procedure might improve the predictions and make the procedure uniform, i.e. “standard tools” in drug development would become available.
Keywords: ADME-tox, Caco-2, drug absorption, human intestinal absorption, in silico methods, QSAR, pharmacokinetics, Combinatorial chemistry, Computer-Aided Drug Design, pharmacophore, in vitro
Combinatorial Chemistry & High Throughput Screening
Title: In Silico Predictions of ADME-Tox Properties: Drug Absorption
Volume: 14 Issue: 5
Author(s): Tessy Geerts and Yvan Vander Heyden
Affiliation:
Keywords: ADME-tox, Caco-2, drug absorption, human intestinal absorption, in silico methods, QSAR, pharmacokinetics, Combinatorial chemistry, Computer-Aided Drug Design, pharmacophore, in vitro
Abstract: The accurate prediction of the in vivo pharmacokinetics of a new potential drug compound based on only its virtual structure is the ultimate goal of in silico ADME-Tox property modeling. A comprehensive review is made on recent studies concerning the A (absorption) in ADME-Tox, i.e. the in silico modeling of both Caco-2 permeability and human intestinal absorption. The data sets used, the descriptors selected to build the models, the variable selection methods, the modeling techniques and the performed model validation are critically discussed. It was concluded that reliable models which improve the success rate of compound selection and drug development are still lacking. Limiting the quality of the models are, for instance, inappropriate compilation of data sets, lack of an appropriate outlier detection and unrepresentativeness of training and test sets for the data population. The definition of some best practices or guidelines for the different steps of the modeling procedure might improve the predictions and make the procedure uniform, i.e. “standard tools” in drug development would become available.
Export Options
About this article
Cite this article as:
Geerts Tessy and Vander Heyden Yvan, In Silico Predictions of ADME-Tox Properties: Drug Absorption, Combinatorial Chemistry & High Throughput Screening 2011; 14 (5) . https://dx.doi.org/10.2174/138620711795508359
DOI https://dx.doi.org/10.2174/138620711795508359 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Advances in the design of antibody & protein with conformational dynamics and artificial intelligence approaches
“Antibodies & Protein Design” section focuses on the utilization of multiple strategies to engineer and optimize antibodies and proteins that serve diverse analytical strategies, such as combinatorial protein design, structure-based design, sequence-based design, and other techniques that incorporate principles of protein-protein interactions, allosteric regulation, and post-translational modifications. Example applications include ...read more
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute-force experimentation, which can be time-consuming and resource-intensive. Spectral graph theory, a branch of mathematics dealing with the properties of graphs in relation to the eigenvalues and eigenvectors of matrices associated ...read more
Intersection of Chemical Graph Theory and Molecular Sciences
Chemical graph theory has become increasingly critical in molecular sciences, offering advanced capabilities in the modeling, design, and analysis of chemical structures via molecular graphs. This special issue aims to not only explore these fundamental aspects but also to push the boundaries of CCHTS applications. By integrating the concept of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Curcumin and Curcumin Derivatives for Therapeutic Applications:
<i>In vitro</i> and <i>In vivo</i> Studies
Current Nutrition & Food Science Magainin-Related Peptides Stimulate Insulin-Release and Improve Glucose Tolerance in High Fat Fed Mice
Protein & Peptide Letters The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Current Medicinal Chemistry Essential Structure of the κ Opioid Receptor Agonist Nalfurafine for Binding to the κ Receptor
Current Pharmaceutical Design Strategies of Functional Foods Promote Sleep in Human Being
Current Signal Transduction Therapy Vitamin D as a Potential Therapeutic Option in Cancer Treatment: Is There a Role for Chemoprevention?
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Characterization and Evaluation of Cytotoxicity of New Aminophosphonic Acid Diesters in Human Leukemia Cells
Letters in Drug Design & Discovery Implications of PEGylation of Carbon Nanotubes for Central Nervous System Bioavailability
CNS & Neurological Disorders - Drug Targets Hsp90 Quaternary Structures and the Chaperone Cycle: Highly Flexible Dimeric and Oligomeric Structures and Their Regulation by Co-Chaperones
Current Proteomics Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy
Current Medicinal Chemistry DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus
Current Pharmaceutical Design Identification of SER-PRO-CYS Peptide in Blood Serum of Multiple Sclerosis Patients
Protein & Peptide Letters Iron Oxide Nanoparticles: An Insight into their Biomedical Applications
Current Medicinal Chemistry Transcriptome Analysis of mRNA in Uterine Leiomyoma Using Next-generation RNA Sequencing
Anti-Cancer Agents in Medicinal Chemistry G-quadruplex DNA Aptamers and their Ligands: Structure, Function and Application
Current Pharmaceutical Design Metabolite Identification and Profiling in Drug Design: Current Practice and Future Directions
Current Pharmaceutical Design Significance of Color Spaces and Their Selection for Image Processing: A Survey
Recent Advances in Computer Science and Communications Emerging Trends in Abuse-Deterrent Formulations: Technological Insights and Regulatory Considerations
Current Drug Delivery A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling
Current Medicinal Chemistry Neurological Disorders in Medical Use of <i>Cannabis</i>: An Update
CNS & Neurological Disorders - Drug Targets